Sanofi (NASDAQ:SNY) Shares Acquired by Procyon Advisors LLC

Procyon Advisors LLC lifted its position in Sanofi (NASDAQ:SNY) by 2.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,441 shares of the company’s stock after purchasing an additional 277 shares during the period. Procyon Advisors LLC’s holdings in Sanofi were worth $552,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC purchased a new stake in shares of Sanofi during the 3rd quarter worth about $29,000. Concord Wealth Partners grew its holdings in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares during the period. Fortitude Family Office LLC increased its position in shares of Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after buying an additional 659 shares in the last quarter. Sunbelt Securities Inc. raised its stake in shares of Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after buying an additional 313 shares during the period. Finally, Versant Capital Management Inc acquired a new position in shares of Sanofi during the 4th quarter worth approximately $54,000. 14.04% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Sanofi presently has an average rating of “Moderate Buy” and an average target price of $57.50.

Sanofi Price Performance

Shares of Sanofi stock opened at $50.74 on Friday. The stock has a market capitalization of $128.77 billion, a P/E ratio of 25.89, a PEG ratio of 1.17 and a beta of 0.57. The business has a 50 day simple moving average of $48.46 and a two-hundred day simple moving average of $52.09. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Friday, October 25th. The company reported $1.57 EPS for the quarter, beating the consensus estimate of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The firm had revenue of $13.44 billion during the quarter, compared to the consensus estimate of $16.59 billion. During the same period in the prior year, the company earned $2.55 EPS. The firm’s revenue was up 12.3% compared to the same quarter last year. As a group, analysts predict that Sanofi will post 3.94 EPS for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.